Australia signs deal with AstraZeneca for possible COVID-19 vaccine

Singapore News News

Australia signs deal with AstraZeneca for possible COVID-19 vaccine
Singapore Latest News,Singapore Headlines
  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 66%

SYDNEY: Australia has signed a deal with drugmaker AstraZeneca to secure a potential COVID-19 vaccine, the prime minister said on Tuesday (Aug ...

SYDNEY: Australia has signed a deal with drugmaker AstraZeneca to secure a potential COVID-19 vaccine, the prime minister said on Tuesday , joining a growing list of countries lining up supplies of the drug.

"Under this deal we have secured early access for every Australian," Prime Minister Scott Morrison said in an emailed statement. Countries around the world are looking to secure supplies of Astrazeneca's potential vaccine. Most recently Argentina and Mexico said last week they would produce it for much of Latin America.Morrison, however, cautioned that while AstraZeneca's candidate is showing early promise, there was no guarantee it would materialise as an effective tool in preventing COVID-19.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ChannelNewsAsia /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Britain encourages at-risk groups to sign up for Covid-19 vaccine trialsBritain encourages at-risk groups to sign up for Covid-19 vaccine trialsLONDON (REUTERS) - Britain on Monday (Aug 17) urged elderly people and volunteers from Black and Asian minority groups to sign up to a Covid-19 vaccine trial registry to boost efforts to find a working vaccine against the disease that offers protection against higher risk groups.. Read more at straitstimes.com.
Read more »

China grants country's first COVID-19 vaccine patent to CanSino: ReportChina grants country's first COVID-19 vaccine patent to CanSino: ReportChina's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media ...
Read more »

Testing of CanSino's COVID-19 candidate vaccine begins in RussiaTesting of CanSino's COVID-19 candidate vaccine begins in RussiaMOSCOW: A late-stage trial of a COVID-19 candidate vaccine from CanSino Biologics has started in Russia, registration records showed, as the ...
Read more »

Novavax begins mid-stage study of COVID-19 vaccine in South AfricaNovavax begins mid-stage study of COVID-19 vaccine in South AfricaJOHANNESBURG: US drug developer Novavax said on Monday (Aug 17) that it is starting a mid-stage study of its experimental COVID-19 vaccine in ...
Read more »

China grants country's first Covid-19 vaccine patent to CanSinoChina grants country's first Covid-19 vaccine patent to CanSinoBEIJING (REUTERS) - China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator.. Read more at straitstimes.com.
Read more »

Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trialPakistan gives go-ahead to Phase 3 COVID-19 vaccine trialPakistan's drug regulator greenlit the country's first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by ...
Read more »



Render Time: 2025-04-13 16:28:05